Baseline and interval laboratory monitoring should include: fasting glucose and HbA1c (tirzepatide can cause hypoglycemia in non-diabetic subjects if caloric intake drops too low), lipase and amylase (pancreatitis risk with GLP-1 agonists), liver function tests (AST, ALT, bilirubin), and thyroid panel (TSH, free T3, free T4)
However, it does come in higher concentrations, so always be aware of what you have if giving at home
My view has not changed: BPC-157 lacks adequate human evidence for ulcerative colitis, Crohn's disease or "gut healing", and it should not replace established IBD treatment
Semaglutide weight loss effects Semaglutide is a familiar FDA-approved medication used for weight management
Researchers planning new work should consult the most current literature on this compound class to position findings against the broader mechanism-niche framework
Some may start with frequent injections (e.g., weekly) then taper to monthly or as maintenance
